Instituto de Diagnóstico S.A. (INDISA.SN)

1,441.90 +4.60 (+0.32%) At close: 02:58PM CLT

Instituto de Diagnóstico S.A.

Avda. Santa MarIa 1810
Providencia
Chile
56 22 362 5555
https://www.indisa.cl

Sector(s): Healthcare
Industry: Medical Care Facilities
Full-time employees: 2,973

Description

Instituto de Diagnóstico S.A. engages in the provision of general and specialized health services in Chile. It offers patient information, and doctors and specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hospitalization, adult critical patient unit, ward and surgical procedures, neonatology, and robotic surgery; and telemedicine services comprising online consultation and rehabilitation. In addition, it operates health centers, which includes metabolic surgery and nutrition, thyroid and parathyroid, physical medicine and rehabilitation, endometriosis, sleep, hemodynamics service, and dialysis centers. Further, the company offers catastrophic, ambulatory, hospitalized, and oncological insurances, as well as accident agreements. Instituto de Diagnóstico S.A. was founded in 1961 and is headquartered in Providencia, Chile.

Corporate governance

Instituto de Diagnóstico S.A.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.